Serum Uric Acid Levels in Parkinson’s Disease: A Cross-Sectional Electronic Medical Record Database Study from a Tertiary Referral Centre in Romania
Open Access
Abstract
Background and Objectives: Parkinson’s disease (PD) is a prevalent neurodegenerative condition responsible for progressive motor and non-motor symptoms. Currently, no prophylactic or disease-modifying interventions are available. Uric acid (UA) is a potent endogenous antioxidant, resulting from purine metabolism. It is responsible for about half of the antioxidant capacity of the plasma. Increasing evidence suggests that lower serum UA levels are associated with an increased risk of developing PD and with faster disease progression. Materials and Methods: We conducted an electronic medical record database study to investigate the associations between UA levels and different characteristics of PD. Results: Out of 274 datasets from distinct patients with PD, 49 complied with the predefined inclusion and exclusion criteria. Lower UA levels were significantly associated with the severity of parkinsonism according to the Hoehn and Yahr stage (rs = 0.488, p = 0.002), with the motor complications of long-term dopaminergic treatment (r = 0.333, p = 0.027), and with the presence of neurocognitive impairment (r = 0.346, p = 0.021). Conclusions: Oxidative stress is considered a key player in the etiopathogenesis of PD, therefore the involvement of lower UA levels in the development and progression of PD is plausible. Data on the potential therapeutic roles of elevating serum UA (e.g., by precursor administration or diet manipulation) are scarce, but considering the accumulating epidemiological evidence, the topic warrants further research.Keywords
Funding Information
- Autoritatea Natională pentru Cercetare Stiintifică (CNFISFDI-2021-0300)
This publication has 63 references indexed in Scilit:
- Effect of Urate-Elevating Inosine on Early Parkinson Disease ProgressionJAMA, 2021
- Higher urate in LRRK2 mutation carriers resistant to Parkinson diseaseAnnals of Neurology, 2019
- Plasma urate and risk of Parkinson's disease: A mendelian randomization studyAnnals of Neurology, 2018
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- Genetic variability related to serum uric acid concentration and risk of Parkinson's diseaseMovement Disorders, 2013
- Higher serum uric acid associated with decreased Parkinson's disease prevalence in a large community‐based surveyMovement Disorders, 2010
- Gout and the risk of parkinson's disease: A cohort studyArthritis Care & Research, 2008
- Uric acid in Parkinson's diseaseMovement Disorders, 2008
- Low plasma uric acid level in Parkinson's diseaseMovement Disorders, 2007
- Serum uric acid levels and the risk of Parkinson diseaseAnnals of Neurology, 2005